Impact on malaria morbidity of a programme supplying insecticide treated nets in children aged under 2 years in Tanzania: community cross sectional study

被引:109
作者
Abdulla, S
Armstrong, J
Schellenberg, A
Nathan, R
Mukasa, O
Marchant, T
Smith, T
Tanner, M
Lengeler, C
机构
[1] Swiss Trop Inst, Basel, Switzerland
[2] Ifakara Hlth Res & Dev Ctr, Ifakara, Tanzania
来源
BMJ-BRITISH MEDICAL JOURNAL | 2001年 / 322卷 / 7281期
关键词
D O I
10.1136/bmj.322.7281.270
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To assess the impact of a social marketing programme for distributing nets treated with insecticide on malarial parasitaemia and anaemia in very young children in an area of high malaria transmission. Design Community cross sectional study. Annual, cross sectional data were collected at the beginning of the social marketing campaign (1997) and the subsequent two years. Net ownership and other risk and confounding factors were assessed with a questionnaire. Blood samples were taken from the children to assess prevalence of parasitaemia and haemoglobin levels. Setting 18 villages in the Kilombero and Ulanga districts of southwestern Tanzania. participants A random sample of children aged under 2 years. Main outcome measures The presence of any parasitaemia in the peripheral blood sample and the presence of anaemia (classified as a haemoglobin level of <80 g/l). Results Ownership of nets increased rapidly (treated or not treated nets: from 58% to 83%; treated nets: from 10% to 61%). The mean haemoglobin level rose from 80 g/l to 89 g/l in the stud children in the successive surveys. Overall, the prevalence of anaemia in the stud population decreased from 49% to 26% in the two years studied. Treated nets had a protective efficacy of 62% (95% confidence interval 38% to 77%) on the prevalence of parasitaemia and of 63% (27% to 82%) on anaemia. Conclusions These results show that nets treated with insecticide have a substantial impact on morbidity when distributed in a public health setting.
引用
收藏
页码:270 / 273
页数:4
相关论文
共 15 条
  • [1] [Anonymous], 1991, DIS MORTALITY SUBSAH
  • [2] BEYOND CHLOROQUINE - IMPLICATIONS OF DRUG-RESISTANCE FOR EVALUATING MALARIA THERAPY EFFICACY AND TREATMENT POLICY IN AFRICA
    BLOLAND, PB
    LACKRITZ, EM
    KAZEMBE, PN
    WERE, JBO
    STEKETEE, R
    CAMPBELL, CC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (04) : 932 - 937
  • [3] Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years
    Hatz, C
    Abdulla, S
    Mull, R
    Schellenberg, D
    Gathmann, I
    Kibatala, P
    Beck, HP
    Tanner, M
    Royce, C
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 1998, 3 (06) : 498 - 504
  • [4] Kitua AY, 1997, TROP MED INT HEALTH, V2, P325
  • [5] Plasmodium falciparum malaria in the first year of life in an area of intense and perennial transmission
    Kitua, AY
    Smith, T
    Alonso, PL
    Masanja, H
    Urassa, H
    Menendez, C
    Kimario, J
    Tanner, M
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 1996, 1 (04) : 475 - 484
  • [6] Langeler C, 1996, B WORLD HEALTH ORGAN, V74, P325
  • [7] Lengeler C, 2000, COCHRANE DATABASE SY
  • [8] *MAL CONS LOND SCH, 1999, 2 INT C INS TREAT NE
  • [9] Marsh K, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P241
  • [10] Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants
    Menendez, C
    Kahigwa, E
    Hirt, R
    Vounatsou, P
    Aponte, JJ
    Font, F
    Acosta, CJ
    Schellenberg, DM
    Galindo, CM
    Kimario, J
    Urassa, H
    Brabin, B
    Smith, TA
    Kitua, AY
    Tanner, M
    Alonso, PL
    [J]. LANCET, 1997, 350 (9081) : 844 - 850